Alimera Sciences' ILUVIEN® Receives Marketing Authorization In Norway For The Treatment Of Chronic Diabetic Macular Edema
July 28, 2014Alimera Sciences announced the Norwegian Medicines Evaluation Board has granted marketing authorization to ILUVIEN® for the treatment of vision impairment associated with chronic diabetic macular edema (DME) considered unresponsive to current therapies.
More »
Astute Medical And Ortho-Clinical Diagnostics Enter Strategic Collaboration To Advance Innovative Acute Kidney Injury Test
July 28, 2014Astute Medical, Inc. announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. (OCD) that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition.
More »
Esperion Therapeutics Announces Initiation of a Phase 2 Clinical Study of ETC-1002 in Patients with Hypercholesterolemia and Hypertension
July 24, 2014Esperion Therapeutics announced dosing of the first patient in the Phase 2 clinical study of their therapy, ETC-1002, in patients with hypercholesterolemia and hypertension, ETC-1002-014.
More »